1. Home
  2. WD vs ICUI Comparison

WD vs ICUI Comparison

Compare WD & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WD
  • ICUI
  • Stock Information
  • Founded
  • WD 1937
  • ICUI 1984
  • Country
  • WD United States
  • ICUI United States
  • Employees
  • WD N/A
  • ICUI N/A
  • Industry
  • WD Finance: Consumer Services
  • ICUI Medical/Dental Instruments
  • Sector
  • WD Finance
  • ICUI Health Care
  • Exchange
  • WD Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • WD 2.8B
  • ICUI 3.2B
  • IPO Year
  • WD 2010
  • ICUI 1992
  • Fundamental
  • Price
  • WD $62.76
  • ICUI $132.91
  • Analyst Decision
  • WD Buy
  • ICUI Buy
  • Analyst Count
  • WD 2
  • ICUI 6
  • Target Price
  • WD $96.00
  • ICUI $183.60
  • AVG Volume (30 Days)
  • WD 232.2K
  • ICUI 289.0K
  • Earning Date
  • WD 11-06-2025
  • ICUI 11-06-2025
  • Dividend Yield
  • WD 4.28%
  • ICUI N/A
  • EPS Growth
  • WD 20.18
  • ICUI N/A
  • EPS
  • WD 3.37
  • ICUI N/A
  • Revenue
  • WD $1,160,070,000.00
  • ICUI $2,320,363,000.00
  • Revenue This Year
  • WD $18.92
  • ICUI N/A
  • Revenue Next Year
  • WD $8.31
  • ICUI N/A
  • P/E Ratio
  • WD $18.60
  • ICUI N/A
  • Revenue Growth
  • WD 17.65
  • ICUI N/A
  • 52 Week Low
  • WD $61.25
  • ICUI $107.00
  • 52 Week High
  • WD $114.04
  • ICUI $175.51
  • Technical
  • Relative Strength Index (RSI)
  • WD 22.73
  • ICUI 55.58
  • Support Level
  • WD $61.25
  • ICUI $132.16
  • Resistance Level
  • WD $69.19
  • ICUI $138.48
  • Average True Range (ATR)
  • WD 2.52
  • ICUI 5.48
  • MACD
  • WD -1.26
  • ICUI 0.18
  • Stochastic Oscillator
  • WD 7.25
  • ICUI 48.94

About WD Walker & Dunlop Inc

Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: